ストックスクリーナーアプリを入手
1.51
4.86%
0.07
前日終値:
$1.44
開ける：
$1.44
24時間の取引高:
57,160
Relative Volume:
0.07
時価総額：
$2.97M
収益：
$29.78M
当期純損益:
$-39.94M
株価収益率:
-0.0244
EPS:
-61.9139
ネットキャッシュフロー:
$-16.12M
1週間 パフォーマンス:
-11.70%
1か月 パフォーマンス:
-25.25%
6か月 パフォーマンス:
-95.09%
1年 パフォーマンス:
-99.42%
1日の値動き範囲:
$1.32
$1.51
1週間の範囲:
$1.32
$1.75
52週間の値動き範囲:
$1.32
$581.85
22nd Century Group, Inc. Stock (XXII) Company Profile
名前
22nd Century Group, Inc.
セクター
電話
716-270-1523
住所
8560 Main Street, Williamsville, NY
XXII を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
1.51 | 2.97M | 29.78M | -39.94M | -16.12M | -61.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-07-21 | 開始されました | Alliance Global Partners | Buy |
| 2022-06-15 | 開始されました | Craig Hallum | Buy |
| 2022-03-08 | 開始されました | ROTH Capital | Buy |
| 2021-07-23 | 開始されました | Cowen | Outperform |
| 2017-10-16 | 繰り返されました | Chardan Capital Markets | Buy |
| 2016-08-11 | 繰り返されました | Chardan Capital Markets | Buy |
すべてを表示
22nd Century Group, Inc. (XXII) 最新ニュース
22nd Century Group, Inc. (NASDAQ:XXII) Q4 2024 Earnings Call Transcript - Insider Monkey
22nd Century reports $15.5 million loss for 2024; no net revenue from very-low-nicotine line - Winston-Salem Journal
22nd Century Group Inc (XXII) Q4 2024 Earnings Call Highlights: Navigating Challenges and ... - Yahoo Canada Finance
22nd Century outlines plans for VLN expansion and growth in 2025 - MSN
22nd Century Group Inc (XXII) Q4 2024 Earnings Call Highlights: Navigating Challenges and ... By GuruFocus - Investing.com Canada
22nd Century Group Inc (XXII) Q4 2024 Earnings Call Highlights: Navigating Challenges and Strategic Repositioning - GuruFocus.com
22nd Century Group Reports 2024 Financial Results - TipRanks
Earnings call transcript: 22nd Century Group Q4 2024 sees revenue drop By Investing.com - Investing.com South Africa
Earnings call transcript: 22nd Century Group Q4 2024 sees revenue drop - Investing.com Canada
22nd Century Group, Inc. SEC 10-K Report - TradingView
22nd Century Group reports annual financial results - Investing.com
22nd Century Group Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
22nd Century Group, Inc. Unveils 2025 Growth Strategy and Announces First VLN® Partner Brand with Smoker Friendly - Nasdaq
22nd Century Group reports annual financial results By Investing.com - Investing.com UK
22nd Century Group Earnings Reveal Major Transformation Plan as Losses Mount - StockTitan
22nd Century Group Earnings: CEO and CFO to Unveil Full Year Performance March 20 - StockTitan
22nd Century Group, Inc. to Host Webcast on March 20, 2025, for 2024 Financial Results and Future Plans - Nasdaq
22nd Century Group to Announce Fourth Quarter and Full Year 2024 Results on March 20, 2025 - The Manila Times
12 Cannabis Stocks to Buy Now in 2025 - MarketBeat
22nd Century Announces First Partner VLN Agreement, New VLN Availability with Smoker Friendly - GlobeNewswire
22nd Century Group expands VLN products with Smoker Friendly By Investing.com - Investing.com Australia
22nd Century Group expands VLN products with Smoker Friendly - Investing.com India
22nd Century Launches Reduced Nicotine Cigarettes Through Major Partnership - StockTitan
XXII stock plunges to 52-week low, touches $3.03 amid market rout - MSN
Weiss Ratings Reiterates “Sell (E)” Rating for 22nd Century Group (NASDAQ:XXII) - Defense World
XXII stock plunges to 52-week low of $1.72 amid market challenges - Investing.com Australia
22nd Century regains compliance with the Nasdaq - MSN
XXII stock plunges to 52-week low of $2.98 amid market challenges - Investing.com Nigeria
XXII stock plunges to 52-week low of $2.98 amid market challenges By Investing.com - Investing.com South Africa
22nd Century Group (NASDAQ:XXII) Given “Sell (E+)” Rating at Weiss Ratings - Defense World
Emerging Growth Research Releases New Initiation Report on the 22nd Century Group (XXII) - Newsfile
22nd Century : FDA Lead Scientist Discusses 22nd Century’s SPECTRUM® Research Cigarettes in Public Webcast - Marketscreener.com
22nd Century Group, Inc. (NASDAQ:XXII) Short Interest Down 63.8% in January - Defense World
XXII stock plunges to 52-week low, touches $3.03 amid market rout By Investing.com - Investing.com South Africa
22nd Century to Present at the Emerging Growth Conference on February 19, 2025 - Marketscreener.com
Exclusive: 22nd Century Group Unveils Strategic Vision at Emerging Growth ConferenceCEO Takes Center Stage - StockTitan
Weiss Ratings Reiterates Sell (E) Rating for 22nd Century Group (NASDAQ:XXII) - Defense World
22nd Century files to sell 104,124 shares of common stock for holders - MSN
22nd Century Sells Cannabis Operations - Tobacco Reporter
Investors Buy 22nd Shares ‘Above Market’ - Tobacco Reporter
22nd Century Launches Public Offering - Tobacco Reporter
22nd Century Submits CBD Drug Master File - Tobacco Reporter
22nd Century Eliminates $2.3 million of Debt - Tobacco Reporter
22nd Century Reports Quarterly Results - Tobacco Reporter
22nd Century Group, Inc. (XXII) 財務データ
収益
当期純利益
現金流量
EPS
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):